A PHASE IB TRIAL OF CEDIRANIB IN ADDITION TO STANDARD TEMOZOLOMIDE AND RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

被引：0
|
作者：
Chi, Andrew S. [1 ]
Gerstner, Elisabeth R. [1 ]
Eichler, April F. [1 ]
Chea, Houng K. [1 ]
Shearer, Nancy [1 ]
Drappatz, Jan [2 ]
Wen, Patrick Y. [2 ]
Ivy, S. Percy [3 ]
Loeffler, Jay S. [4 ]
Sorensen, A. Gregory [5 ]
Jain, Rakesh K. [4 ]
Batchelor, Tracy T. [1 ]
机构：
[1] Massachusetts Gen Hosp, Dept Neurol, Div Neurooncol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dana Farber Brigham & Womens Canc Ctr, Ctr Neurooncol, Boston, MA USA
[3] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
[4] Harvard Univ, Sch Med, Dept Radiat Oncol, Massachusetts Gen Hosp, Boston, MA USA
[5] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：946 / 947
页数：2
相关论文
共 50 条
  • [1] Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma
    Chi, A. S.
    Gerstner, E. R.
    Eichler, A. F.
    Chea, H. K.
    Drappatz, J.
    Wen, P. Y.
    Ivy, S. P.
    Loeffler, J. S.
    Sorensen, A. G.
    Jain, R. K.
    Batchelor, T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Safety of idroxioleic acid in combination with standard of care (temozolomide and/or radiation therapy) in newly diagnosed glioblastoma patients: A phase Ib trial
    Balana, C.
    del Barco Berron, S.
    Stradella, A.
    Villanueva Vazquez, R.
    Cuesta, A.
    Torres, J. V.
    Roma, J.
    Taylor, R.
    Escriba, P. V.
    Llobet, E.
    McNicholl, A. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S518 - S518
  • [3] CHLOROBRAIN phase IB trial; The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma
    Compter, I.
    Eekers, D.
    Hoeben, A.
    Rouschop, K.
    Reymen, B. J.
    Ackermans, L.
    Beckervordersantforth, J.
    Bauer, N.
    Anten, M.
    Wesseling, P.
    Postma, A.
    De Ruysscher, D.
    Lambin, P.
    ANNALS OF ONCOLOGY, 2019, 30 : 154 - 154
  • [4] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [5] The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
    Vredenburgh, James J.
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Herndon, James E., II
    Marcello, Jennifer
    Kirkpatrick, John P.
    Sampson, John H.
    Bailey, Leighann
    Threatt, Stevie
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4119 - 4124
  • [6] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
  • [7] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [8] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [9] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [10] Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Compter, Inge
    Eekers, Danielle B. P.
    Hoeben, Ann
    Rouschop, Kasper M. A.
    Reymen, Bart
    Ackermans, Linda
    Beckervordersantforth, Jan
    Bauer, Noel J. C.
    Anten, Monique M.
    Wesseling, Pieter
    Postma, Alida A.
    De Ruysscher, Dirk
    Lambin, Philippe
    AUTOPHAGY, 2021, 17 (09) : 2604 - 2612
12345